Literature DB >> 25191484

Segmental lung lavage with fiberoptic bronchoscopy in a patient with special presentation of pulmonary alveolar proteinosis.

Hasan Allah Sadeghi1.   

Abstract

Pulmonary alveolar proteinosis (PAP) is rare. It is characterized by the accumulation of proteinaceous materials in the alveoli. Typical appearance of BAL fluid (BALF) and positive PAS staining of BALF in conjunction with typical clinical and radiographic manifestations may be diagnostic of PAP. The current mainstay of treatment for PAP is whole-lung lavage. Therapy with granulocyte-macrophage colony stimulating factor is also an option. An alternative procedure is selective lobar/segmental lavage by fiberoptic bronchoscopy (FOB). Whole lung lavage with FOB for idiopathic PAP is currently a safe procedure in an experienced setting, and could be considered in patients with less severe lung involvement who cannot tolerate general anesthesia for the whole lung lavage. It provides long-lasting benefits. We report here our experiences with segmental lung lavage by FOB in a patient with vary severe PAP since she could not undergo whole long lavage under general anesthesia. The one year follow up results are also reported.

Entities:  

Keywords:  Fiberoptic bronchoscopy; Pulmonary alveolar proteinosis; Segmental lung lavage

Year:  2013        PMID: 25191484      PMCID: PMC4153261     

Source DB:  PubMed          Journal:  Tanaffos        ISSN: 1735-0344


  8 in total

Review 1.  Pulmonary alveolar proteinosis.

Authors:  Bruce C Trapnell; Jeffrey A Whitsett; Koh Nakata
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

2.  Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis.

Authors:  Haruyuki Ishii; Bruce C Trapnell; Ryushi Tazawa; Yoshikazu Inoue; Masanori Akira; Yoshihito Kogure; Keisuke Tomii; Toshinori Takada; Masayuki Hojo; Toshio Ichiwata; Hajime Goto; Koh Nakata
Journal:  Chest       Date:  2009-11       Impact factor: 9.410

Review 3.  Diagnosing pulmonary alveolar proteinosis. A review and an update.

Authors:  B M Wang; E J Stern; R A Schmidt; D J Pierson
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

Review 4.  Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction.

Authors:  Sara R Greenhill; Darrell N Kotton
Journal:  Chest       Date:  2009-08       Impact factor: 9.410

5.  Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage.

Authors:  Shih-Lung Cheng; Hou-Tai Chang; Hon-Ping Lau; Li-Na Lee; Pan-Chyr Yang
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

6.  Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.

Authors:  M Beccaria; M Luisetti; G Rodi; A Corsico; M C Zoia; S Colato; P Pochetti; A Braschi; E Pozzi; I Cerveri
Journal:  Eur Respir J       Date:  2004-04       Impact factor: 16.671

7.  Pulmonary alveolar proteinosis: clinical features and outcomes.

Authors:  L S Goldstein; M S Kavuru; P Curtis-McCarthy; H A Christie; C Farver; J K Stoller
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

8.  Quantitative analysis of longitudinal response to aerosolized granulocyte-macrophage colony-stimulating factor in two adolescents with autoimmune pulmonary alveolar proteinosis.

Authors:  Terry E Robinson; Bruce C Trapnell; Michael L Goris; Lynne M Quittell; David N Cornfield
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

  8 in total
  2 in total

1.  A case of autoimmune pulmonary alveolar proteinosis with severe respiratory failure treated with segmental lung lavage and oral statin therapy.

Authors:  Tomotsugu Takano; Keisuke Takeda; Satoshi Nakamura; Genta Akiyama; Nobuhisa Ando; Masashi Komori
Journal:  Respir Med Case Rep       Date:  2022-06-06

2.  Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia.

Authors:  Yu Matsumoto; Takeshi Masuda; Tatsuki Takahashi; Kaori Hashimoto; Kakuhiro Yamaguchi; Shinjiro Sakamoto; Yasushi Horimasu; Taku Nakashima; Shintaro Miyamoto; Hiroshi Iwamoto; Shinichiro Ohshimo; Kazunori Fujitaka; Masahiro Yamasaki; Hironobu Hamada; Noboru Hattori
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.